Skip to content
10-K

Annual Report

PHARMAGEN, INC.

0001477932-14-001427

← back to feed
Filed
Mar 31, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Mar 11, 2014 498.58M sh
Capex FY 2013 · Dec 31, 2013 $56.7K
Capex FY 2013 · Dec 31, 2012 $94K
Operating Cash Flow FY 2013 · Dec 31, 2013 −$692.07K
Operating Cash Flow FY 2013 · Dec 31, 2012 −$2.18M
Short Term Debt FY 2013 · Dec 31, 2013 $500K
Short Term Debt FY 2013 · Dec 31, 2012 $750K
Cash And Equivalents FY 2013 · Dec 31, 2013 $225.98K
Cash And Equivalents FY 2013 · Dec 31, 2012 $322.56K
Cash And Equivalents FY 2013 · Dec 31, 2011 $38.66K
Stockholders Equity FY 2013 · Dec 31, 2013 −$7.71M
Stockholders Equity FY 2013 · Dec 31, 2012 −$2.69M
Stockholders Equity FY 2013 · Dec 31, 2011 −$369.75K
Current Liabilities FY 2013 · Dec 31, 2013 $8.1M
Current Liabilities FY 2013 · Dec 31, 2012 $2.43M
Total Liabilities FY 2013 · Dec 31, 2013 $8.87M
Total Liabilities FY 2013 · Dec 31, 2012 $5.59M
Current Assets FY 2013 · Dec 31, 2013 $879.31K
Current Assets FY 2013 · Dec 31, 2012 $1.59M
Total Assets FY 2013 · Dec 31, 2013 $1.28M
Total Assets FY 2013 · Dec 31, 2012 $2.9M
Sga Expense FY 2013 · Dec 31, 2013 $2.1M
Sga Expense FY 2013 · Dec 31, 2012 $1.67M
Net Income FY 2013 · Dec 31, 2013 −$6M
Net Income FY 2013 · Dec 31, 2012 −$2.77M
Operating Income FY 2013 · Dec 31, 2013 −$3.61M
Operating Income FY 2013 · Dec 31, 2012 −$2.1M
Gross Profit FY 2013 · Dec 31, 2013 $3.05M
Gross Profit FY 2013 · Dec 31, 2012 $1.26M
Cost Of Revenue FY 2013 · Dec 31, 2013 $1.77M
Cost Of Revenue FY 2013 · Dec 31, 2012 $3M
Revenue FY 2013 · Dec 31, 2013 $4.81M
Revenue restated FY 2013 · Dec 31, 2012 $4.26M